Skills in Healthcare awarded Investors in People Platinum standard

Skills in Healthcare, the contract sales arm of Alliance Healthcare, has achieved the Investors in People Platinum Standard.

The internationally recognised accreditation is the sign of a great employer and an outperforming place to work. The IIP Platinum accreditation is the highest accolade that can be achieved against the Investors in People Standard and is currently held by only 1% of IIP accredited organisations. The Standard is underpinned by a rigorous assessment methodology and framework where the assessor explored the processes and systems.In order to secure the accreditation, evidence was gathered and assessed via employee and candidate interviews carried out by the Investors in People assessor.

Paul Fowler, Head of Skills in Healthcare, said:"I am really proud of my team in achieving this external recognition. In 2016 we achieved a Gold standard so to go one better and reach Platinum this time is a great way to demonstrate to our clients just how great all our Skills in Healthcare people are."

Comments from Investors in People:

• They are an example of an organisation that has delivered continued business growth since Skills in Healthcare's inception in 2011.
• The team truly embraced the principles of IiP and strived to provide effective people management and development in order to achieve high levels of engagement across all its teams.
• Impressed with the style of leadership (at all levels) that encourages and supports effective collaboration, an inclusive approach.
• A real sense of a ‘family feel' amongst the wider Skills in Healthcare team – made even more remarkable by the fact that a large proportion of people are ‘field based' and therefore work remotely on a day-to-day basis.
• There was also an overwhelming sense of genuine pride, engagement and commitment from the staff – people enjoy working for the organisation and clearly want it to be a success

Alliance Healthcare Your Docs Has a New Home

Alliance Healthcare has developed its latest functionality – ‘Your Docs', on the Alliance Healthcare Portal, a system that provides customers with a simplified approach to access multiple Alliance Healthcare systems and order products online, including surgical orders from NWOS.

As part of its digital evolution, Alliance Healthcare has moved the old ‘Your Docs' system to the new Alliance Healthcare Portal, with the following customer benefits:

• Convenient – 24/7 access to your statements, invoices and credit notes from the past 6 months
• User friendly – we've simplified the searching tool
• Paper-free – reduce clutter by storing your statements on your computer as a PDF"
•  

Over 11,000 customers have now registered for the portal. Kate from Cooper's Pharmacy, Belfast said: "It is extremely easy to use. I can check quickly if something is in stock. It also allows me to place and track NWOS orders as well. We just can't imagine now not using it!"

The portal is accessible at www.myahportal.co.ukand customers can self-register in just 15 minutes.

To support customers during the registration and in using the Portal, a ChatBot system has been enabled that offers instant question and answer support for the user. Online support is also available via email at: customerportal@alliance-healthcare.co.uk, and a helpline on 0330 100 0448 - option 8, for any technical support and assistance.

The old Your Docs system has now closed.

Class 2 Recall on Mepacrine Hydrochloride 100 Mg Tablets

BCM Specials Limited has informed us that a number of foreign body particulates including glass and rubber have been found in one of the containers of the Active Pharmaceutical Ingredient (API) used in the manufacture of Mepacrine Hydrochloride 100mg tablets. A small amount of the affected API (comparative to the API present in batch 85641) has been used in the manufacture of batch 85641 Mepacrine Hydrochloride tablets.

Class 4 Caution in Use on Depo-Provera 150mg/Ml Injection (1ml Vial)

Drugsrus Ltd (distributor) / Tenolol Ltd (MA Holder) has informed us of a typographical error in active ingredient stated on the label on the vial. The active ingredient should be "medroxyprogesterone acetate" (a long acting contraceptive) however, it is stated as "methylpredinisolone acetate" (a corticosteroid) in error.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch

Alliance do not stockDepo-Provera 150mg/Ml Injection (1ml Vial)Drugsrus Ltd (distributor) / Tenolol Ltd (MA Holder)AT0604
X44095

Alliance healthcare do not stock this product and as this is a caution in use only we are not accepting stock returns.

For more information or medical information enquiries please contact info@drugsrus.co.uk or call on 020 8423 3800

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

Coloplast Ltd – Solus Agreement

From 6th June 2020, Alliance Healthcare UK will become the only wholesaler to supply the Coloplast Ltd Ostomy and Continence product portfolio to all pharmacies and dispensing doctors in the United Kingdom.

The Coloplast Wound Care portfolio is excluded from this agreement and will remain unchanged from its current distribution model.

If you have any queries, please speak to your Alliance Healthcare Account Manager.

Class 2 Recall on Epistatus 10mg/mL Oromucosal

Torbay Pharmaceuticals has informed us that the child-resistant container closure for Epistatus 10mg/mL Oromucosal Solution (Multi Dose Bottles) may be faulty and incorrectly engaged. The child resistant closure can potentially be removed without unscrewing the cap closure. Removal of an incorrectly engaged cap closure will result in the yellow tamper evident band not being retained on the neck of the bottle. It should be noted that this product is manufactured as an unlicensed special..

Nestle Health Science – Dual Agreement

Nestle Health Science – Dual Agreement

From 1 May 2020, Alliance Healthcare UK will become one of the two wholesalers to supply Nestle Health Science products to all pharmacies, Hospitals, and dispensing doctors in the United Kingdom. The other wholesaler in this agreement is Phoenix.

If you have any queries, please speak to your Alliance Healthcare Account Manager

Class 4 Caution in use Sodium Benzoate (Amzoate) 2g in 10 mL Sterile Solution for injection

Torbay Pharmaceuticals has informed us that the carton label on Sodium Benzoate (Amzoate) 2g in 10 mL Sterile Solution for injection incorrectly states the concentration of disodium edetate (excipient) as 0.1% w/v (10mg in 1mL) instead of 0.1% w/v (10mg in 10mL).

Class 2 Recall on Emerade 500 microgram auto-injectors

Pharmaswiss Ceska republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 500 microgram auto-injectors (also referred to as pens) from patients due to an error in one component of the auto-injector believed to cause some pens to fail to activate and deliver adrenaline.

Class 4 Caution in Use on GSK various products

GSK has informed us that due to a machinery defect with the printing line, a small number of packs may not have the batch number and expiry date printed on the outer cartons. The correct information is printed on the blister pack and there is no concern with the product quality.